Schedule 13G ownership disclosure

COCRYSTAL PHARMA INC

Security class unavailable · CUSIP: 19188J300

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,738,120
Percent of class
5.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-22-000022
Form type
SC 13G/A
Filer
Cocrystal Pharma, Inc.
CIK
CIK 1412486
Filed
Jan 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub